2023-05-01 2024-04-30 true No description of principal activity Capium Accounts Production 1.1 08992422 bus:AbridgedAccounts 2023-05-01 2024-04-30 08992422 bus:Micro-entities 2023-05-01 2024-04-30 08992422 bus:AuditExempt-NoAccountantsReport 2023-05-01 2024-04-30 08992422 bus:SmallCompaniesRegimeForAccounts 2023-05-01 2024-04-30 08992422 bus:PrivateLimitedCompanyLtd 2023-05-01 2024-04-30 08992422 2023-05-01 2024-04-30 08992422 2024-04-30 08992422 bus:RegisteredOffice 2023-05-01 2024-04-30 08992422 core:WithinOneYear 2024-04-30 08992422 core:AfterOneYear 2024-04-30 08992422 bus:Director1 2023-05-01 2024-04-30 08992422 bus:Director1 2024-04-30 08992422 bus:Director1 2022-05-01 2023-04-30 08992422 bus:Director2 2023-05-01 2024-04-30 08992422 bus:Director2 2024-04-30 08992422 bus:Director2 2022-05-01 2023-04-30 08992422 bus:Director3 2023-05-01 2024-04-30 08992422 bus:Director3 2024-04-30 08992422 bus:Director3 2022-05-01 2023-04-30 08992422 2022-05-01 08992422 bus:LeadAgentIfApplicable 2023-05-01 2024-04-30 08992422 2022-05-01 2023-04-30 08992422 2023-04-30 08992422 core:WithinOneYear 2023-04-30 08992422 core:AfterOneYear 2023-04-30 08992422 bus:EntityAccountantsOrAuditors 2022-05-01 2023-04-30 08992422 core:CostValuation core:Non-currentFinancialInstruments 2024-04-30 08992422 core:CostValuation core:Non-currentFinancialInstruments 2023-04-30 08992422 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2024-04-30 08992422 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2024-04-30 08992422 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2024-04-30 08992422 core:Non-currentFinancialInstruments 2024-04-30 08992422 core:Non-currentFinancialInstruments 2023-04-30 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 08992422
England and Wales

 

 

 

VALUPAK VITAMINS LIMITED


Dormant Accounts
 


Period of accounts

Start date: 01 May 2023

End date: 30 April 2024
  2024   2023
    £ £   £ £
Current assets 1      1   
Net current assets   1      1 
Total assets less current liabilities   1      1 
Net assets   1      1 
 

         
Capital and reserves   1      1 
 
NOTES TO THE ACCOUNTS

General Information
Valupak Vitamins Limited is a private company, limited by shares, registered in England and Wales, registration number 08992422, registration address Clayton Wood Close, West Park Ring Road, Leeds, LS16 6QE.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 105 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
2.

Average number of employees

Average number of employees during the year was 3 (2023 : 3).

For the year ended 30 April 2024 the company was entitled to exemption from audit under Section 480 of the Companies Act 2006 relating to dormant companies.

Directors' responsibilities:
The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

These accounts have been prepared in accordance with the micro-entity provisions and FRS 105, the Financial Reporting Standard applicable to the micro-entities regime. The accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The income statement has not been delivered to the Registrar of Companies.


The members have agreed to the preparation of abridged accounts.
The financial statements were approved by the board of directors on 21 October 2024 and were signed on its behalf by:


--------------------------------
Z M M Abu Sheikha
Director
1